Zobrazeno 1 - 6
of 6
pro vyhledávání: '"David M. Metter"'
Publikováno v:
Baylor University Medical Center Proceedings. 32:116-118
We present the case of a 32-year-old African American woman with a giant malignant phyllodes tumor that metastasized to the lungs and subsequently the brain. Her treatment included six cycles of adjuvant therapy with AIM (Adriamycin(®), ifosfamide,
Publikováno v:
Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons. 78(12)
An association between granulocyte colony-stimulating factor therapy (G-CSFT) in patients with glycogen storage disease type Ib (GSDIb) and the development of giant cell lesions of the maxillofacial complex has emerged. We have reported, to the best
Publikováno v:
JAMA network open. 2(5)
Importance The current state of the US pathologist workforce is uncertain, with deficits forecast over the next 2 decades. Objective To examine the trends in the US pathology workforce from 2007 to 2017. Design, Setting, and Participants A cross-sect
Carcinoma en cuirasse (CeC) is an extremely rare form of cutaneous metastasis of breast cancer. Guidelines for diagnosis and treatment of CeC are limited due to the small number of reported cases. It can be difficult to distinguish CeC from benign et
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::704c3a93a0e0a16994f5aaf79e86c458
https://europepmc.org/articles/PMC6541069/
https://europepmc.org/articles/PMC6541069/
Publikováno v:
Baylor University Medical Center Proceedings. 31:514-515
Plasma cell neoplasms consist of a spectrum of diseases characterized by monoclonal proliferations of plasma cells. We report the simultaneous presentation of two distinct plasma cell neoplasms, a very uncommon situation.
Publikováno v:
Baylor University Medical Center Proceedings. 30:203-204
Breast plasmacytomas are extremely rare entities that can be seen as primary malignant neoplasms in the absence of bone involvement or as secondary neoplasms from disseminated multiple myeloma. Clinicians should be aware of this entity, as it may mim